|4Sep 14, 5:20 PM ET

Adams Helen C. 4

4 · Immix Biopharma, Inc. · Filed Sep 14, 2023

Insider Transaction Report

Form 4
Period: 2023-09-12
Transactions
  • Purchase

    Common Stock

    2023-09-12$2.96/sh+13,000$38,49213,000 total
Footnotes (1)
  • [F1]This figure is the weighted average sales price of multiple trades ranging from $2.90 to $3.25 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.

Documents

1 file
  • 4
    ownership.xmlPrimary